VALEDA - Tyson Eye | Dry AMD VALEDA Light Delivery System is the First and Only FDA-Authorized Treatment for Dry Age-Related Macular Degeneration (AMD) to show visual improvements during clinical trials VALEDA treats Dry AMD by using Photobi omodulation (PBM), to apply specific wavelengths of light to the eye
LumiThera LumiThera is the leader in ophthalmic photobiomodulation (PBM) with the Valeda® Light Delivery System Valeda is the first and only FDA-authorized treatment for dry age-related macular degeneration (AMD) to improve vision
New Therapy Brings Hope for Dry AMD Vision Loss - WebMD The trial found that LumiThera’s Valeda Light Delivery System significantly reduced the risk of vision loss and the start of geographic atrophy in dry AMD More than 58% of the people studied
Valeda Locator – Valeda – Healthcare Professionals – USA How to use the Valeda Locator Type the city or nearest to you into the search box and select a search radius from the drop-down Click the “Search” button Click on a map pin to view the contact details for the practice You can reset the map to the beginning at any time by clicking on the “Reset” button
Encouraging results from light therapy study for dry AMD The Valeda photobiomodulation technique uses three wavelengths of light to stimulate the layer of cells in the back of the eye called the retinal pigment epithelium (RPE), to keep them healthy for longer
Valeda – Healthcare Professionals – Global Backed by extensive research and designed to optimize therapeutic benefits, Valeda is an essential addition for managing patients with dry age-related macular degeneration (AMD) Valeda is the first photobiomodulation (PBM) device designed specifically for ophthalmic applications
Valeda – Treatment for Dry Macular Degeneration On November 4, 2024, the FDA approved the first and only treatment for Dry Age-Related Macular Degeneration (AMD) in the U S , the Valeda® Light Delivery System The Valeda® treatment was approved in Europe in 2019
FDA Authorizes Light Therapy for Dry AMD - American Academy . . . The FDA authorized light therapy for dry AMD based on results from a small study of 100 people in the early stages of the disease, treating some with LumiThera’s Valeda Light Delivery System in nine short sessions over 3 to 5 weeks This was repeated every four months, for a total of 2 years